These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 36232728)

  • 1. In Vitro Models for Studying Chronic Drug-Induced Liver Injury.
    Donato MT; Gallego-Ferrer G; Tolosa L
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human liver organoid screening platform for DILI risk prediction.
    Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
    J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury.
    Proctor WR; Foster AJ; Vogt J; Summers C; Middleton B; Pilling MA; Shienson D; Kijanska M; Ströbel S; Kelm JM; Morgan P; Messner S; Williams D
    Arch Toxicol; 2017 Aug; 91(8):2849-2863. PubMed ID: 28612260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
    Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
    Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
    Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
    Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
    Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
    Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
    Albrecht W; Kappenberg F; Brecklinghaus T; Stoeber R; Marchan R; Zhang M; Ebbert K; Kirschner H; Grinberg M; Leist M; Moritz W; Cadenas C; Ghallab A; Reinders J; Vartak N; van Thriel C; Golka K; Tolosa L; Castell JV; Damm G; Seehofer D; Lampen A; Braeuning A; Buhrke T; Behr AC; Oberemm A; Gu X; Kittana N; van de Water B; Kreiling R; Fayyaz S; van Aerts L; Smedsrød B; Ellinger-Ziegelbauer H; Steger-Hartmann T; Gundert-Remy U; Zeigerer A; Ullrich A; Runge D; Lee SML; Schiergens TS; Kuepfer L; Aguayo-Orozco A; Sachinidis A; Edlund K; Gardner I; Rahnenführer J; Hengstler JG
    Arch Toxicol; 2019 Jun; 93(6):1609-1637. PubMed ID: 31250071
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mirahmad M; Sabourian R; Mahdavi M; Larijani B; Safavi M
    Drug Metab Rev; 2022 May; 54(2):161-193. PubMed ID: 35403528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of potential hepatotoxicity induced by drugs.
    Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
    Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicogenomics of drug induced liver injury - from mechanistic understanding to early prediction.
    Lauschke VM
    Drug Metab Rev; 2021 May; 53(2):245-252. PubMed ID: 33683927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering.
    Donato MT; Jover R; Gómez-Lechón MJ
    Curr Drug Metab; 2013 Nov; 14(9):946-68. PubMed ID: 24160292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.
    Tolosa L; Jiménez N; Pelechá M; Castell JV; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2019 Feb; 93(2):519-532. PubMed ID: 30426164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver Injury.
    Shi Q; Arefin A; Ren L; Papineau KS; Barnette DA; Schnackenberg LK; Hawes JJ; Avigan M; Mendrick DL; Ewart L; Ronxhi J
    Curr Protoc; 2022 Jul; 2(7):e478. PubMed ID: 35790095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current challenges and controversies in drug-induced liver injury.
    Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
    Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI.
    Howell BA; Yang Y; Kumar R; Woodhead JL; Harrill AH; Clewell HJ; Andersen ME; Siler SQ; Watkins PB
    J Pharmacokinet Pharmacodyn; 2012 Oct; 39(5):527-41. PubMed ID: 22875368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.